Is ANI Pharmaceuticals, Inc. (ANIP) a Buy, Sell, or Hold?
NASDAQ : ANIP
ANI Pharmaceuticals, Inc.
$79.2 USD
-$2.72 (-3.32%)
- Volume
- 313.64K
- Average Volume
- 345.21K
- Market Capitalization
- $1.8B
- P/E Ratio
- 19.27
- Dividend Yield
- 0.00%
- Price Target
- $91.00
- Year High
- $99.50
- Year Low
- $62.61
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.01
- Current Ratio
- $3.12
Insider Activity Summary (Last 12 Months)
Insiders Buying
17
Insiders Selling
80
Amount of Insider Selling
$341.13K
ANIP Insider Buying/Selling by Quarter
ANIP Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 2026-07-13 | S-Sale | 81.84 | 2026-07-14 |
| CAREY STEPHEN P. | officer: SVP & CFO | 2026-07-02 | M-Exempt | 49.51 | 2026-07-06 |
| CAREY STEPHEN P. | officer: SVP & CFO | 2026-07-02 | S-Sale | 86 | 2026-07-06 |
| CAREY STEPHEN P. | officer: SVP & CFO | 2026-07-02 | M-Exempt | 49.51 | 2026-07-06 |
| CAREY STEPHEN P. | officer: SVP & CFO | 2026-06-29 | S-Sale | 84.12 | 2026-06-30 |
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 2026-06-12 | S-Sale | 82.03 | 2026-06-15 |
| Thoma Jeanne | director | 2026-05-21 | A-Award | 0 | 2026-06-10 |
| TANNENBAUM RENEE P | director | 2026-05-21 | A-Award | 0 | 2026-06-10 |
| Pera Antonio R | director | 2026-05-21 | A-Award | 0 | 2026-06-10 |
| Leonard Matthew J | director | 2026-05-21 | A-Award | 0 | 2026-06-10 |
| HAUGHEY THOMAS | director | 2026-05-21 | A-Award | 0 | 2026-06-10 |
| HAUGHEY THOMAS | director | 2026-06-08 | S-Sale | 80.88 | 2026-06-10 |
| CAREY STEPHEN P. | officer: SVP & CFO | 2026-06-05 | M-Exempt | 49.51 | 2026-06-09 |
| CAREY STEPHEN P. | officer: SVP & CFO | 2026-06-05 | S-Sale | 80 | 2026-06-09 |
| CAREY STEPHEN P. | officer: SVP & CFO | 2026-06-05 | M-Exempt | 49.51 | 2026-06-09 |
| Walsh Patrick D | director | 2026-05-11 | S-Sale | 80.75 | 2026-05-13 |
| Walsh Patrick D | director | 2026-05-13 | S-Sale | 80.63 | 2026-05-13 |
| Rowland Thomas Andrew | officer: SVP, HEAD - ESTABLISHED BRANDS | 2026-05-12 | S-Sale | 79.21 | 2026-05-13 |
| Lalwani Nikhil | director, officer: PRESIDENT & CEO | 2026-05-11 | S-Sale | 77.57 | 2026-05-13 |
| Gutwerg Ori | officer: SVP, GENERICS | 2026-05-12 | S-Sale | 79.5 | 2026-05-13 |
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 2026-05-13 | S-Sale | 78.16 | 2026-05-13 |
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 2026-04-13 | S-Sale | 77.95 | 2026-04-13 |
| Rowland Thomas Andrew | officer: SVP, HEAD - ESTABLISHED BRANDS | 2026-03-11 | S-Sale | 74.91 | 2026-03-13 |
| Mutz Christopher | officer: HEAD OF RARE DISEASE | 2026-03-13 | S-Sale | 71.64 | 2026-03-13 |
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 2026-03-13 | S-Sale | 72.62 | 2026-03-13 |
| Mutz Christopher | officer: HEAD OF RARE DISEASE | 2026-03-06 | S-Sale | 74.22 | 2026-03-10 |
| Mutz Christopher | officer: HEAD OF RARE DISEASE | 2026-03-07 | F-InKind | 74.04 | 2026-03-10 |
| Mutz Christopher | officer: HEAD OF RARE DISEASE | 2026-03-09 | S-Sale | 74.18 | 2026-03-10 |
| Lalwani Nikhil | director, officer: PRESIDENT & CEO | 2026-03-07 | F-InKind | 74.04 | 2026-03-10 |
| Gutwerg Ori | officer: SVP, GENERICS | 2026-03-07 | F-InKind | 74.04 | 2026-03-10 |
| Davis Krista | officer: SVP, CHIEF HR OFFICER | 2026-03-06 | S-Sale | 75 | 2026-03-10 |
| Davis Krista | officer: SVP, CHIEF HR OFFICER | 2026-03-09 | S-Sale | 74.13 | 2026-03-10 |
| CAREY STEPHEN P. | officer: SVP & CFO | 2026-03-07 | F-InKind | 74.04 | 2026-03-10 |
| CAREY STEPHEN P. | officer: SVP & CFO | 2026-03-05 | M-Exempt | 49.51 | 2026-03-05 |
| CAREY STEPHEN P. | officer: SVP & CFO | 2026-03-05 | S-Sale | 75.42 | 2026-03-05 |
| CAREY STEPHEN P. | officer: SVP & CFO | 2026-03-05 | S-Sale | 75.56 | 2026-03-05 |
| CAREY STEPHEN P. | officer: SVP & CFO | 2026-03-05 | M-Exempt | 49.51 | 2026-03-05 |
| Mutz Christopher | officer: HEAD OF RARE DISEASE | 2026-03-02 | S-Sale | 74 | 2026-03-04 |
| Gutwerg Ori | officer: SVP, GENERICS | 2026-03-03 | S-Sale | 76.5 | 2026-03-04 |
| Walsh Patrick D | director | 2026-03-03 | S-Sale | 74.23 | 2026-03-03 |
| Shanmugam Muthusamy | director, officer: HEAD OF R&D, COO-NOVITIUM OPS | 2026-02-26 | A-Award | 77.15 | 2026-03-02 |
| Rowland Thomas Andrew | officer: SVP, HEAD - ESTABLISHED BRANDS | 2026-02-26 | A-Award | 77.15 | 2026-03-02 |
| Rowland Thomas Andrew | officer: SVP, HEAD - ESTABLISHED BRANDS | 2026-02-28 | F-InKind | 73.9 | 2026-03-02 |
| Mutz Christopher | officer: HEAD OF RARE DISEASE | 2026-02-26 | A-Award | 77.15 | 2026-03-02 |
| Mutz Christopher | officer: HEAD OF RARE DISEASE | 2026-02-28 | F-InKind | 73.9 | 2026-03-02 |
| Lalwani Nikhil | director, officer: PRESIDENT & CEO | 2026-02-26 | A-Award | 77.15 | 2026-03-02 |
| Lalwani Nikhil | director, officer: PRESIDENT & CEO | 2026-02-28 | F-InKind | 73.9 | 2026-03-02 |
| Gutwerg Ori | officer: SVP, GENERICS | 2026-02-26 | A-Award | 77.15 | 2026-03-02 |
| Gutwerg Ori | officer: SVP, GENERICS | 2026-02-28 | F-InKind | 73.9 | 2026-03-02 |
| Gassert Chad | officer: SVP - CORP. DEV. & STRATEGY | 2026-02-26 | A-Award | 77.15 | 2026-03-02 |
| Gassert Chad | officer: SVP - CORP. DEV. & STRATEGY | 2026-02-28 | F-InKind | 73.9 | 2026-03-02 |
| Davis Krista | officer: SVP, CHIEF HR OFFICER | 2026-02-26 | A-Award | 77.15 | 2026-03-02 |
| Davis Krista | officer: SVP, CHIEF HR OFFICER | 2026-02-28 | F-InKind | 73.9 | 2026-03-02 |
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 2026-02-26 | A-Award | 77.15 | 2026-03-02 |
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 2026-02-28 | F-InKind | 73.9 | 2026-03-02 |
| CAREY STEPHEN P. | officer: SVP & CFO | 2026-02-26 | A-Award | 77.15 | 2026-03-02 |
| CAREY STEPHEN P. | officer: SVP & CFO | 2026-02-28 | F-InKind | 73.9 | 2026-03-02 |
| Mutz Christopher | officer: HEAD OF RARE DISEASE | 2026-02-20 | S-Sale | 78.02 | 2026-02-23 |
| Davis Krista | officer: SVP, CHIEF HR OFFICER | 2026-02-19 | S-Sale | 77.53 | 2026-02-23 |
| Davis Krista | officer: SVP, CHIEF HR OFFICER | 2026-02-20 | S-Sale | 77.99 | 2026-02-23 |
| Rowland Thomas Andrew | officer: SVP, HEAD - ESTABLISHED BRANDS | 2026-02-12 | F-InKind | 76.7 | 2026-02-17 |
| Rowland Thomas Andrew | officer: SVP, HEAD - ESTABLISHED BRANDS | 2026-02-14 | F-InKind | 77.36 | 2026-02-17 |
| Mutz Christopher | officer: HEAD OF RARE DISEASE | 2026-02-12 | F-InKind | 76.7 | 2026-02-17 |
| Mutz Christopher | officer: HEAD OF RARE DISEASE | 2026-02-12 | S-Sale | 76.55 | 2026-02-17 |
| Mutz Christopher | officer: HEAD OF RARE DISEASE | 2026-02-14 | F-InKind | 77.36 | 2026-02-17 |
| Lalwani Nikhil | director, officer: PRESIDENT & CEO | 2026-02-12 | F-InKind | 76.7 | 2026-02-17 |
| Lalwani Nikhil | director, officer: PRESIDENT & CEO | 2026-02-14 | F-InKind | 77.36 | 2026-02-17 |
| Gutwerg Ori | officer: SVP, GENERICS | 2026-02-12 | F-InKind | 76.7 | 2026-02-17 |
| Gutwerg Ori | officer: SVP, GENERICS | 2026-02-14 | F-InKind | 77.36 | 2026-02-17 |
| Gassert Chad | officer: SVP - CORP. DEV. & STRATEGY | 2026-02-12 | F-InKind | 76.7 | 2026-02-17 |
| Gassert Chad | officer: SVP - CORP. DEV. & STRATEGY | 2026-02-14 | F-InKind | 77.36 | 2026-02-17 |
| Davis Krista | officer: SVP, CHIEF HR OFFICER | 2026-02-12 | F-InKind | 76.7 | 2026-02-17 |
| Davis Krista | officer: SVP, CHIEF HR OFFICER | 2026-02-14 | F-InKind | 77.36 | 2026-02-17 |
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 2026-02-12 | F-InKind | 76.7 | 2026-02-17 |
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 2026-02-13 | S-Sale | 76.8 | 2026-02-17 |
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 2026-02-14 | F-InKind | 77.36 | 2026-02-17 |
| CAREY STEPHEN P. | officer: SVP & CFO | 2026-02-12 | F-InKind | 76.7 | 2026-02-17 |
| CAREY STEPHEN P. | officer: SVP & CFO | 2026-02-14 | F-InKind | 77.36 | 2026-02-17 |
| CAREY STEPHEN P. | officer: SVP & CFO | 2026-02-11 | F-InKind | 76.25 | 2026-02-13 |
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 2026-02-11 | F-InKind | 76.25 | 2026-02-13 |
| Davis Krista | officer: SVP, CHIEF HR OFFICER | 2026-02-11 | F-InKind | 76.25 | 2026-02-13 |
| Gassert Chad | officer: SVP - CORP. DEV. & STRATEGY | 2026-02-11 | F-InKind | 76.25 | 2026-02-13 |
| Gutwerg Ori | officer: SVP, GENERICS | 2026-02-11 | F-InKind | 76.25 | 2026-02-13 |
| Lalwani Nikhil | director, officer: PRESIDENT & CEO | 2026-02-11 | F-InKind | 76.25 | 2026-02-13 |
| Mutz Christopher | officer: HEAD OF RARE DISEASE | 2026-02-11 | F-InKind | 76.25 | 2026-02-13 |
| Rowland Thomas Andrew | officer: SVP, HEAD - ESTABLISHED BRANDS | 2026-02-11 | F-InKind | 76.25 | 2026-02-13 |
| Shanmugam Muthusamy | director, officer: HEAD OF R&D, COO-NOVITIUM OPS | 2026-02-11 | F-InKind | 76.25 | 2026-02-13 |
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 2026-01-13 | S-Sale | 84.33 | 2026-01-14 |
| Davis Krista | officer: SVP, CHIEF HR OFFICER | 2025-12-18 | S-Sale | 82.4 | 2025-12-19 |
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 2025-12-12 | S-Sale | 82.32 | 2025-12-12 |
| TANNENBAUM RENEE P | director | 2025-12-05 | S-Sale | 81.15 | 2025-12-09 |
| Walsh Patrick D | director | 2025-11-13 | S-Sale | 86.88 | 2025-11-17 |
| Walsh Patrick D | director | 2025-11-13 | G-Gift | 0 | 2025-11-17 |
| Gassert Chad | officer: SVP - CORP. DEV. & STRATEGY | 2025-11-12 | S-Sale | 89.07 | 2025-11-14 |
| Gassert Chad | officer: SVP - CORP. DEV. & STRATEGY | 2025-11-13 | S-Sale | 88 | 2025-11-14 |
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 2025-11-13 | S-Sale | 87.27 | 2025-11-14 |
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 2025-10-13 | S-Sale | 90.09 | 2025-10-14 |
| Davis Krista | officer: SVP, CHIEF HR OFFICER | 2025-09-19 | S-Sale | 98.04 | 2025-09-22 |
| Davis Krista | officer: SVP, CHIEF HR OFFICER | 2025-09-12 | F-InKind | 97.71 | 2025-09-15 |
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 2025-09-12 | S-Sale | 98.42 | 2025-09-15 |